BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34406812)

  • 1. The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection.
    Di Domenico EG; Marchesi F; Cavallo I; Toma L; Sivori F; Papa E; Spadea A; Cafarella G; Terrenato I; Prignano G; Pimpinelli F; Mastrofrancesco A; D'Agosto G; Trento E; Morrone A; Mengarelli A; Ensoli F
    Microbiol Spectr; 2021 Sep; 9(1):e0055021. PubMed ID: 34406812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
    Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
    Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
    Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
    BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of Pathogenic Bacterial Spectrum, Drug Resistance and Risk Factors for Mortality of Bloodstream Infection in Patients with Hematologic Diseases].
    Guo Q; Wang XW; Chen XY; Zhao J; He SL; Tian WW; Ma LM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1556-1562. PubMed ID: 37846716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study.
    Kern WV; Roth JA; Bertz H; Götting T; Dettenkofer M; Widmer AF; Theilacker C;
    Transpl Infect Dis; 2019 Dec; 21(6):e13186. PubMed ID: 31574202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
    Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
    Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.
    Wang L; Wang Y; Fan X; Tang W; Hu J
    Medicine (Baltimore); 2015 Nov; 94(45):e1931. PubMed ID: 26559260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.
    Trecarichi EM; Giuliano G; Cattaneo C; Ballanti S; Criscuolo M; Candoni A; Marchesi F; Laurino M; Dargenio M; Fanci R; Cefalo M; Delia M; Spolzino A; Maracci L; Bonuomo V; Busca A; Principe MID; Daffini R; Simonetti E; Dragonetti G; Zannier ME; Pagano L; Tumbarello M;
    Int J Antimicrob Agents; 2023 Jun; 61(6):106806. PubMed ID: 37030470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
    Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
    J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
    El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
    J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey.
    Trecarichi EM; Pagano L; Candoni A; Pastore D; Cattaneo C; Fanci R; Nosari A; Caira M; Spadea A; Busca A; Vianelli N; Tumbarello M;
    Clin Microbiol Infect; 2015 Apr; 21(4):337-43. PubMed ID: 25595706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013.
    Chen CY; Tien FM; Sheng WH; Huang SY; Yao M; Tang JL; Tsay W; Tien HF; Hsueh PR
    Int J Antimicrob Agents; 2017 Mar; 49(3):272-281. PubMed ID: 28109554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culture-proven Bloodstream Infections at a Specialist Pediatric Hospital.
    Al Yazidi LS; Outhred AC; Britton PN; Kesson A
    Pediatr Infect Dis J; 2020 Jun; 39(6):500-506. PubMed ID: 32221167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.
    Trecarichi EM; Pagano L; Martino B; Candoni A; Di Blasi R; Nadali G; Fianchi L; Delia M; Sica S; Perriello V; Busca A; Aversa F; Fanci R; Melillo L; Lessi F; Del Principe MI; Cattaneo C; Tumbarello M;
    Am J Hematol; 2016 Nov; 91(11):1076-1081. PubMed ID: 27428072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of bloodstream infections in burn patients: An 11-year retrospective study.
    Patel BM; Paratz JD; Mallet A; Lipman J; Rudd M; Muller MJ; Paterson DL; Roberts JA
    Burns; 2012 Aug; 38(5):685-90. PubMed ID: 22348799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing
    Liang T; Xu C; Cheng Q; Tang Y; Zeng H; Li X
    Microb Drug Resist; 2021 Jun; 27(6):800-808. PubMed ID: 33232654
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population.
    Laupland KB; Kirkpatrick AW; Church DL; Ross T; Gregson DB
    J Hosp Infect; 2004 Oct; 58(2):137-45. PubMed ID: 15474185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
    Cattaneo C; Di Blasi R; Skert C; Candoni A; Martino B; Di Renzo N; Delia M; Ballanti S; Marchesi F; Mancini V; Orciuolo E; Cesaro S; Prezioso L; Fanci R; Nadali G; Chierichini A; Facchini L; Picardi M; Malagola M; Orlando V; Trecarichi EM; Tumbarello M; Aversa F; Rossi G; Pagano L;
    Ann Hematol; 2018 Sep; 97(9):1717-1726. PubMed ID: 29705860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influx of multidrug-resistant, gram-negative bacteria in the hospital setting and the role of elderly patients with bacterial bloodstream infection.
    Pop-Vicas A; Tacconelli E; Gravenstein S; Lu B; D'Agata EM
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):325-31. PubMed ID: 19220162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiology and prognostic prediction model of bloodstream infection in patients with hematological malignancies.
    Wang J; Wang M; Zhao A; Zhou H; Mu M; Liu X; Niu T
    Front Cell Infect Microbiol; 2023; 13():1167638. PubMed ID: 37457950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.